Giselle Sholler
Clinical trials sponsored by Giselle Sholler, explained in plain language.
-
Promising drug may stop deadly childhood cancer's return
Disease control OngoingThis study tests an oral drug called DFMO in children and young adults with high-risk neuroblastoma who are currently in remission. The goal is to see if taking DFMO for two years can prevent the cancer from coming back. The trial involves 441 participants and focuses on safety a…
Phase: PHASE2 • Sponsor: Giselle Sholler • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Promising combo targets hard-to-treat childhood cancer
Disease control OngoingThis study tests whether combining two drugs, DFMO and etoposide, can help children and young adults (up to age 30) whose neuroblastoma has come back or not responded to standard treatment. About 131 participants will receive the drug combination to see if it delays cancer growth…
Phase: PHASE2 • Sponsor: Giselle Sholler • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC